Article
Discovery of wall teichoic acid inhibitors as potential anti-MRSA β-lactam combination agents.
Chemistry & biology - 21 Feb 2013
Wang Hao, Gill Charles J, Lee Sang H, Mann Paul, Zuck Paul, Meredith Timothy C, Murgolo Nicholas, She Xinwei, Kales Susan, Liang Lianzhu, Liu Jenny, Wu Jin, Santa Maria John, Su Jing, Pan Jianping, Hailey Judy, Mcguinness Debra, Tan Christopher M, Flattery Amy, Walker Suzanne, Black Todd, Roemer Terry
Abstract excerpt
Innovative strategies are needed to combat drug resistance associated with methicillin-resistant Staphylococcus aureus (MRSA). Here, we investigate the potential of wall teichoic acid (WTA) biosynthesis inhibitors as combination agents to restore β-lactam efficacy against MRSA. Performing a whole-cell pathway-based screen, we identified a series of WTA inhibitors (WTAIs) targeting the WTA transporter protein,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
